Beta-I
-
DATABASE (2973)
-
ARTICLES (471)
Co-founder, CTO of Meatable
Daan Luining is the Dutch co-founder and CTO at cell-based meat startup Meatable, the first to claim a highly scalable culture technology, where he has worked since 2018. He is also a research director at the Cellular Agriculture Society in Leiden, a joint initiative for cell-based startups to share knowledge and to collaborate on projects to further scale the sector. Luining is also on the board of directors at the not-for-profit Cultured Meat Foundation that promotes sector innovation. His past posts have all been in the area of research, either as a researcher or a technician, and at the same time as completing studies. His last job was as a research strategist at New York-based New Harvest, a callular food rsearch funding body, where he worked for a year and met Dr. Kotter, the inventor of Meatable’s cellular technology. His research positions from 2009–15 were in the area of cell culture, mass spectrometry and DNA sequencing at the Maastricht University, University Medical Center Amsterdam, Utrecht University and Leiden University. Luining holds a master’s in biological sciences from Leiden University in the Netherlands.
Daan Luining is the Dutch co-founder and CTO at cell-based meat startup Meatable, the first to claim a highly scalable culture technology, where he has worked since 2018. He is also a research director at the Cellular Agriculture Society in Leiden, a joint initiative for cell-based startups to share knowledge and to collaborate on projects to further scale the sector. Luining is also on the board of directors at the not-for-profit Cultured Meat Foundation that promotes sector innovation. His past posts have all been in the area of research, either as a researcher or a technician, and at the same time as completing studies. His last job was as a research strategist at New York-based New Harvest, a callular food rsearch funding body, where he worked for a year and met Dr. Kotter, the inventor of Meatable’s cellular technology. His research positions from 2009–15 were in the area of cell culture, mass spectrometry and DNA sequencing at the Maastricht University, University Medical Center Amsterdam, Utrecht University and Leiden University. Luining holds a master’s in biological sciences from Leiden University in the Netherlands.
CEO and co-founder of Xendit
Moses Lo comes from an entrepreneurial family, his father acquired a failing business in Australia and turned it into a successful company. The family business inspired Lo to start his own fashion business in Australia after graduating in finance and commerce at the University of New South Wales in 2010.Lo initially gained work experience as an analyst in 2008 as part of his undergraduate finance and commerce programs in Australia. In 2011, he became an associate at the Boston Consulting Group in Australia. After two years, he was promoted to senior associate but left BCG in 2013 to focus on his menswear ventures until 2014.Lo decided to get first-hand tech startup experience in the Silicon Valley, working at Amazon while completing an MBA program at the University of California, Berkeley. In 2015, he decided to established a P2P payments platform Xendit in Indonesia. The platform has since pivoted into a payment gateway service and became a unicorn in 2021, with Lo as CEO based in California and Jakarta. He was also featured in Forbes’ 30 Under 30 list for Asian figures in finance and venture capital in 2016.
Moses Lo comes from an entrepreneurial family, his father acquired a failing business in Australia and turned it into a successful company. The family business inspired Lo to start his own fashion business in Australia after graduating in finance and commerce at the University of New South Wales in 2010.Lo initially gained work experience as an analyst in 2008 as part of his undergraduate finance and commerce programs in Australia. In 2011, he became an associate at the Boston Consulting Group in Australia. After two years, he was promoted to senior associate but left BCG in 2013 to focus on his menswear ventures until 2014.Lo decided to get first-hand tech startup experience in the Silicon Valley, working at Amazon while completing an MBA program at the University of California, Berkeley. In 2015, he decided to established a P2P payments platform Xendit in Indonesia. The platform has since pivoted into a payment gateway service and became a unicorn in 2021, with Lo as CEO based in California and Jakarta. He was also featured in Forbes’ 30 Under 30 list for Asian figures in finance and venture capital in 2016.
CTO and co-founder of Xendit
Bo Chen is a talented programmer specializing in web development. He graduated from the University of California with a double degree in electrical engineering and computer science. He worked as a web development intern at various companies while studying in the US. He graduated in 2014 and worked briefly at web marketing firm Brandcast and fintech startup Ripple. In 2015, he joined fellow UC Berkeley alumnus Moses Lo to establish Xendit, a payment platform for Southeast Asia.
Bo Chen is a talented programmer specializing in web development. He graduated from the University of California with a double degree in electrical engineering and computer science. He worked as a web development intern at various companies while studying in the US. He graduated in 2014 and worked briefly at web marketing firm Brandcast and fintech startup Ripple. In 2015, he joined fellow UC Berkeley alumnus Moses Lo to establish Xendit, a payment platform for Southeast Asia.
Principal Software Engineer and co-founder of Xendit
Juan Gonzalez is a software and web developer based in San Francisco. He graduated from the University of California with a Computer Science degree in 2013 and worked as a software engineer at Expedia Inc, where he received an award for stellar performance. However, he left Expedia in 2015 to build a P2P payments platform for the Southeast Asian market. He is both co-founder and principal software engineer at Xendit.
Juan Gonzalez is a software and web developer based in San Francisco. He graduated from the University of California with a Computer Science degree in 2013 and worked as a software engineer at Expedia Inc, where he received an award for stellar performance. However, he left Expedia in 2015 to build a P2P payments platform for the Southeast Asian market. He is both co-founder and principal software engineer at Xendit.
Co-founder of Xendit
Vivek Ahuja graduated from the United States Naval Academy with a Quantitative Economics degree in 2008. He went on to receive training for nuclear engineering and submarine officer roles in the US Navy, serving on the nuclear submarine USS Michigan for three years. He left the US Navy in 2013 to pursue an MBA at the University of California, Berkeley. Ahuja was briefly involved as a co-founder of payments gateway Xendit, but left the startup to join fintech company Affirm Inc in 2015.
Vivek Ahuja graduated from the United States Naval Academy with a Quantitative Economics degree in 2008. He went on to receive training for nuclear engineering and submarine officer roles in the US Navy, serving on the nuclear submarine USS Michigan for three years. He left the US Navy in 2013 to pursue an MBA at the University of California, Berkeley. Ahuja was briefly involved as a co-founder of payments gateway Xendit, but left the startup to join fintech company Affirm Inc in 2015.
Co-founder of Meatable
Mark Kotter is the Austrian co-founder at Dutch cell-based meat startup Meatable, the first to use pluripotent stem cells and claim a highly scalable culture technology, which was developed by Kotter prior to founding the startup in 2018. He is also founder at his biotech startup, bit.bio, which is based in Cambridge, UK, since 2016, where he applies his cellular technological innovation to human stem cell research and has raised investments totaling $42m. His main full-time position is at the University of Cambridge, where he has worked since 2009. He has spent more than five years as a clinician-scientist in stem cell research and was previously a lecturer in neurosurgery. Kotter also lectures at Paris Descartes University and is a team leader at the UK’s National Institute for Health Research’s Brain Injury MedTech Co-operative. He also founded Myelopathy.org to raise awareness of cervical myelopathy. His past positions were as a research group leader at the Max Planck Institute for Experimental Medicine for one year, and for two years spent at the Medical University of Vienna. Kotter holds two doctorates; one in philosophy from the University of Cambridge and the other in medicine from the University of Graz in Austria. Kotter also holds a master’s in philosophy from the University of Cambridge.
Mark Kotter is the Austrian co-founder at Dutch cell-based meat startup Meatable, the first to use pluripotent stem cells and claim a highly scalable culture technology, which was developed by Kotter prior to founding the startup in 2018. He is also founder at his biotech startup, bit.bio, which is based in Cambridge, UK, since 2016, where he applies his cellular technological innovation to human stem cell research and has raised investments totaling $42m. His main full-time position is at the University of Cambridge, where he has worked since 2009. He has spent more than five years as a clinician-scientist in stem cell research and was previously a lecturer in neurosurgery. Kotter also lectures at Paris Descartes University and is a team leader at the UK’s National Institute for Health Research’s Brain Injury MedTech Co-operative. He also founded Myelopathy.org to raise awareness of cervical myelopathy. His past positions were as a research group leader at the Max Planck Institute for Experimental Medicine for one year, and for two years spent at the Medical University of Vienna. Kotter holds two doctorates; one in philosophy from the University of Cambridge and the other in medicine from the University of Graz in Austria. Kotter also holds a master’s in philosophy from the University of Cambridge.
Founder of TreeFrog Therapeutics
Kévin Alessandri is CEO, CTO and co-founder of TreeFrog Therapeutics, whose proprietory C-Stem technology mass-produces high-quality pluripotent stem cells in a 3D environment. Prior to founding TreeFrog in 2018, Alessandri spent two years as a post-doctoral fellow at Bordeaux’s Institut d’Optique. During 2014 and 2015, he completed a post-doctorate at the University of Geneva, focused on developing 3D printed microfluidics systems to build 3D cell culture vessels for stem cell applications. From 2008 to 2013 he completed a PhD on cellular capsules technology and applications at the Institut Curie in Paris.
Kévin Alessandri is CEO, CTO and co-founder of TreeFrog Therapeutics, whose proprietory C-Stem technology mass-produces high-quality pluripotent stem cells in a 3D environment. Prior to founding TreeFrog in 2018, Alessandri spent two years as a post-doctoral fellow at Bordeaux’s Institut d’Optique. During 2014 and 2015, he completed a post-doctorate at the University of Geneva, focused on developing 3D printed microfluidics systems to build 3D cell culture vessels for stem cell applications. From 2008 to 2013 he completed a PhD on cellular capsules technology and applications at the Institut Curie in Paris.
Founder of TreeFrog Therapeutics
Maxime Feyeux is President, CSO and co-founder of TreeFrog Therapeutics whose proprietory C-Stem technology mass-produces high-quality pluripotent stem cells in a 3D environment. Prior to founding TreeFrog in 2018, Feyeux worked as a maturation engineer at Aquitaine Science Transfert and completed a post-doctoral degree at Bordeaux’s Institut des Maladies Neurodégénératives. He also has a post-doctoral degree from the University of Geneva and completed his PhD in neurobiology and neurosciences at the Université d’Evry-Val d’Essone.
Maxime Feyeux is President, CSO and co-founder of TreeFrog Therapeutics whose proprietory C-Stem technology mass-produces high-quality pluripotent stem cells in a 3D environment. Prior to founding TreeFrog in 2018, Feyeux worked as a maturation engineer at Aquitaine Science Transfert and completed a post-doctoral degree at Bordeaux’s Institut des Maladies Neurodégénératives. He also has a post-doctoral degree from the University of Geneva and completed his PhD in neurobiology and neurosciences at the Université d’Evry-Val d’Essone.
Founder of TreeFrog Therapeutics
Jean-Luc Treillou is co-founder of TreeFrog Therapeutics, whose proprietory C-Stem technology mass-produces high-quality pluripotent stem cells in a 3D environment. Since January 2019, he has also acted as an advisor and member of the strategic committee of IT security company Eshard. Prior to co-founding TreeFrog, Treillou founded YSOPIA Bioscience in 2011, where he was CEO until he left in 2021, and Chairman of the Board from 2018. Between 2009 and 2013 he held the posts of General Manager and Chairman of the Board at French R&D company Nutrionix.
Jean-Luc Treillou is co-founder of TreeFrog Therapeutics, whose proprietory C-Stem technology mass-produces high-quality pluripotent stem cells in a 3D environment. Since January 2019, he has also acted as an advisor and member of the strategic committee of IT security company Eshard. Prior to co-founding TreeFrog, Treillou founded YSOPIA Bioscience in 2011, where he was CEO until he left in 2021, and Chairman of the Board from 2018. Between 2009 and 2013 he held the posts of General Manager and Chairman of the Board at French R&D company Nutrionix.
Advisor, board member, co-founder of NovoNutrients
Brian Sefton has been co-founder, a board member and a part-time advisor at NovoNutrients, a San Francisco-based biotech manufacturer of alt-protein produced from fermentation and CO2 since it was founded in 2017. In 2009, he co-founded research entity Oakbio, from which NovoNutrients evolved, and was its President and CTO. Sefton was CTO and President at NovoNutrients and also co-CEO and Chief Scientist at Oakbio until 2021 when he became the CEO at San Francisco-based fermentation commercialization startup Sincarne. Between 2005 and 2011, Sefton was also CEO at pharma research company Pharmadyn, working on drugs development for Alzheimer's Disease, and, for three of those years, was also Managing Partner of Stratsyn, a consultancy specializing in creation, development, management and fund raising for not-for-profit organizations. Sefton’s earlier posts include: directing nanotechnology commercialization and investment company Nanosig for three years, CEO of Silicon Valley’s Fastlane, a high-profile pioneer in real-time network traffic and security analysis for six years; and, simultaneously, being CEO at Bluebox Communications, developing high-end network security applications and appliances for Fortune 500 companies and the US government.Sefton holds an MBA from Santa Clara University in California and a bachelor’s degree in biochemistry from the University of California, Berkeley
Brian Sefton has been co-founder, a board member and a part-time advisor at NovoNutrients, a San Francisco-based biotech manufacturer of alt-protein produced from fermentation and CO2 since it was founded in 2017. In 2009, he co-founded research entity Oakbio, from which NovoNutrients evolved, and was its President and CTO. Sefton was CTO and President at NovoNutrients and also co-CEO and Chief Scientist at Oakbio until 2021 when he became the CEO at San Francisco-based fermentation commercialization startup Sincarne. Between 2005 and 2011, Sefton was also CEO at pharma research company Pharmadyn, working on drugs development for Alzheimer's Disease, and, for three of those years, was also Managing Partner of Stratsyn, a consultancy specializing in creation, development, management and fund raising for not-for-profit organizations. Sefton’s earlier posts include: directing nanotechnology commercialization and investment company Nanosig for three years, CEO of Silicon Valley’s Fastlane, a high-profile pioneer in real-time network traffic and security analysis for six years; and, simultaneously, being CEO at Bluebox Communications, developing high-end network security applications and appliances for Fortune 500 companies and the US government.Sefton holds an MBA from Santa Clara University in California and a bachelor’s degree in biochemistry from the University of California, Berkeley
COO and co-founder of Xendit
Tessa Wijaya joined Indonesian fintech Xendit as co-founder and COO in 2016, a year after the payment gateway startup graduated from the Y Combinator program and launched its platform in Indonesia.Wijaya obtained a master’s in philosophy from the University of Sydney in 2006 after graduating from Syracuse University’s Maxwell School of Citizenship and Public Affairs in 2003. She returned to Indonesia and worked as a corporate development officer for over three years. In 2010, she became an analyst at Principia Management Group and Fairways Investment Group, both being Southeast Asia-focused investment firms. In 2013, Wijaya went on to work as an associate at Singapore-based investment firm Mizuho Asia Partners for over three years before joining Xendit back in Jakarta.
Tessa Wijaya joined Indonesian fintech Xendit as co-founder and COO in 2016, a year after the payment gateway startup graduated from the Y Combinator program and launched its platform in Indonesia.Wijaya obtained a master’s in philosophy from the University of Sydney in 2006 after graduating from Syracuse University’s Maxwell School of Citizenship and Public Affairs in 2003. She returned to Indonesia and worked as a corporate development officer for over three years. In 2010, she became an analyst at Principia Management Group and Fairways Investment Group, both being Southeast Asia-focused investment firms. In 2013, Wijaya went on to work as an associate at Singapore-based investment firm Mizuho Asia Partners for over three years before joining Xendit back in Jakarta.
CEO and co-founder of Beyond Leather Materials / Leap
German native Mikael Eydt graduated in economics in 2016 at Erlangen-Nürnberg’s Friedrich-Alexander University. He worked at his family’s hotel company in Germany while studying at university from 2011 to 2016. Eydt also briefly worked in sales for insurance company Debeka and completed his national service as a soldier in Germany. In 2017, Eydt went back to work as a junior manager at family-owned Hotel Eydt in Kirchheim.Currently based in Copenhagen, he is now the CEO and co-founder of Danish alt-leather biotech, Beyond Leather Materials, that produces vegan leather materials from apple waste. He was responsible for the startup’s business development for two years before becoming CEO in July 2020.
German native Mikael Eydt graduated in economics in 2016 at Erlangen-Nürnberg’s Friedrich-Alexander University. He worked at his family’s hotel company in Germany while studying at university from 2011 to 2016. Eydt also briefly worked in sales for insurance company Debeka and completed his national service as a soldier in Germany. In 2017, Eydt went back to work as a junior manager at family-owned Hotel Eydt in Kirchheim.Currently based in Copenhagen, he is now the CEO and co-founder of Danish alt-leather biotech, Beyond Leather Materials, that produces vegan leather materials from apple waste. He was responsible for the startup’s business development for two years before becoming CEO in July 2020.
Chairman of the Board, co-founder, co-inventor of NovoNutrients
Russell J. Howard has been co-founder and chairman of the board at NovoNutrients, a San Francisco biotech manufacturer of alt-protein produced using fermentation and CO2, and the research company Oakbio, since the latter’s foundation in 2009. During this period, for a year, Howard also worked as head of commercial strategy at Genome.One, a genetics startup. Howard is also on the board of executives of two Australian pharma companies, Immutep and NeuClone. Previously, between 1997 and 2009, he was CEO at California-based Maxygen, dedicated to the commercialization of molecular breeding and gene shuffling in protein. The year before that, Howard was president and scientific director at global pharma giant GSK in Santa Clara, and between 1994 and 1996, he held the same position at AFFYMAX Research Institute, working on new drugs research. Howard also held long-term research positions, heading up the laboratory at Palo Alto’s DNAX Research Institute of Molecular & Cellular Biology for six years, and earlier spent nine years at Bethesda’s National Institute of Allergy and Infectious Diseases (NIAID) working on identifying new malarial pathogens. The doctor of biochemistry from the University of Melbourne has over 140 peer-reviewed publications. Following his studies, Howard spent three years undertaking postdoctoral research at Australia’s WEHI (formerly the Walter and Eliza Hall Institute of Medical Research).
Russell J. Howard has been co-founder and chairman of the board at NovoNutrients, a San Francisco biotech manufacturer of alt-protein produced using fermentation and CO2, and the research company Oakbio, since the latter’s foundation in 2009. During this period, for a year, Howard also worked as head of commercial strategy at Genome.One, a genetics startup. Howard is also on the board of executives of two Australian pharma companies, Immutep and NeuClone. Previously, between 1997 and 2009, he was CEO at California-based Maxygen, dedicated to the commercialization of molecular breeding and gene shuffling in protein. The year before that, Howard was president and scientific director at global pharma giant GSK in Santa Clara, and between 1994 and 1996, he held the same position at AFFYMAX Research Institute, working on new drugs research. Howard also held long-term research positions, heading up the laboratory at Palo Alto’s DNAX Research Institute of Molecular & Cellular Biology for six years, and earlier spent nine years at Bethesda’s National Institute of Allergy and Infectious Diseases (NIAID) working on identifying new malarial pathogens. The doctor of biochemistry from the University of Melbourne has over 140 peer-reviewed publications. Following his studies, Howard spent three years undertaking postdoctoral research at Australia’s WEHI (formerly the Walter and Eliza Hall Institute of Medical Research).
CEO and Co-founder of Kuaishou
Su Hua quit his PhD studies at China’s prestigious Tsinghua University. In 2006, he joined Google as an engineer working on ads search. In October 2008, he left Google and started over 33 projects but all failed.A year later, he joined Baidu and worked for over two years as a core engineer and team leader for its search engine marketing system Fengchao. He left Baidu to establish search engine startup One Box that was acquired by Alibaba.In June 2013, Su was introduced to Cheng Yixiao who had already founded GIF Kuaishou in 2011. They decided to join forces and pivot GIF Kuaishou into a video-sharing app, with Su as CEO and Cheng as CPO.
Su Hua quit his PhD studies at China’s prestigious Tsinghua University. In 2006, he joined Google as an engineer working on ads search. In October 2008, he left Google and started over 33 projects but all failed.A year later, he joined Baidu and worked for over two years as a core engineer and team leader for its search engine marketing system Fengchao. He left Baidu to establish search engine startup One Box that was acquired by Alibaba.In June 2013, Su was introduced to Cheng Yixiao who had already founded GIF Kuaishou in 2011. They decided to join forces and pivot GIF Kuaishou into a video-sharing app, with Su as CEO and Cheng as CPO.
CPO and Co-founder of Kuaishou
Cheng Yixiao began his career as a software engineer at HP in Dalian where he met Kuaishou co-founder Yang Yuanxi. Cheng left HP to join Renren as an iPhone client software developer.In 2011, Cheng started a photo-sharing platform GIF Kuaishou and obtained some seed funding. In 2013, he was introduced to a successful entrepreneur Su Hua. They decided to pivot GIF Kuaishou into a video-sharing app, with Cheng as CPO and Su as CEO.Many believe that his earlier experiences of living in Tieling, a county in northeast China, and later in Beijing’s suburb Tiantongyuan, have helped him to identify business opportunities and develop social media tools for the grassroots. He has quite a reputation for his creativity and passion for product development in tech circles.
Cheng Yixiao began his career as a software engineer at HP in Dalian where he met Kuaishou co-founder Yang Yuanxi. Cheng left HP to join Renren as an iPhone client software developer.In 2011, Cheng started a photo-sharing platform GIF Kuaishou and obtained some seed funding. In 2013, he was introduced to a successful entrepreneur Su Hua. They decided to pivot GIF Kuaishou into a video-sharing app, with Cheng as CPO and Su as CEO.Many believe that his earlier experiences of living in Tieling, a county in northeast China, and later in Beijing’s suburb Tiantongyuan, have helped him to identify business opportunities and develop social media tools for the grassroots. He has quite a reputation for his creativity and passion for product development in tech circles.
AlphaBeats: a 10-minute music playlist to de-stress your brain using biofeedback
With the exclusive rights to Philips’s neurofeedback technology, Alphabeats has developed an app to offer and enhance relaxation using a person’s favorite music
Catalonia: Spain's fast-rising robotics hub and next opportunity
With the robotics sector on the rise in Catalonia, expect to see more growth ahead, driving opportunities in related segments, especially services
Sports directory and booking app STRONGBEE helps Indonesians to keep moving, even during Covid-19
Finding trainers, booking gym time and registering for marathons are just some of the activities available through the STRONGBEE app
NutraSign: Farm-to-fork traceability app for healthier lifestyles
NutraSign is an app that lets businesses and consumers identify and trace contaminated products within a food supply chain in seconds, using blockchain technology
Amid Covid-19 gloom, some bright spots in Portugal's tech startup scene
Despite a recession and doubling of the unemployment rate forecast this year, it's not all bad news for the Portuguese tech ecosystem
Didimo: Creator of "digital humans" secures €6.2m in seed funding
Portuguese startup Didimo aims to humanize online interactions with its disruptive 3D technology
Bailian.ai: Using Internet big data, AI to help corporates acquire customers
Previously, a salesperson who got five or six customer leads was considered fortunate. Now, using Bailian.ai, thousands, or even millions, of leads can be found at once
2gether: The world's first crypto-collaborative financial platform
Banking on the opportunities afforded by blockchain, 2gether is owned by its customers who get commission-free financial services in euros and cryptocurrency
In a united move, Portuguese startups fight to mitigate Covid-19 impact in unprecedented crisis
As strong growth of previous years falters, Portugal's startups were quick to mobilize themselves to detail the help they would need from the state to deal with their biggest challenge yet
Faromatics' ChickenBoy robot brings smart analytics to poultry farming
The makers of the AI-based robot for managing large-scale poultry farming are seeking up to €4m in a second round funding as they launch their invention in Europe
How Xiaomi founder Lei Jun became a billionaire by pursuing passion, not fortune
From young man deconstructing and rebuilding smartphones at Kingsoft to top of the smartphone world as founder and chair of Xiaomi, Lei has always let his interests lead the way
Lalibela Global-Networks: A mission to digitalize, move Africa's healthcare system to the cloud
This year’s Web Summit winner, Lalibela Global-Networks, is digitalizing Africa’s paper-based healthcare system in a low-cost, low-code way to save lives and make healthcare affordable
Volantis Technology: Guiding Indonesian enterprises into "Industry 4.0" with end-to-end AI platform
Volantis Technology helps Indonesian companies incorporate digital transformation and make the best use of their data; eyes Singapore office for overseas markets
Portugal oceantech II: Single-minded efforts to build an ecosystem of international reference
With dedicated accelerators and investment programs, supported by the EU’s vote of confidence, Portugal appears on track to lead in oceantech
Icaria Medical's CardioSense: Cardiovascular pre-diagnosis in less than 60 seconds
Icaria Medical is seeking clinical validation and funding for its AI-based monitor, which measures blood pressure continuously and non-invasively
Sorry, we couldn’t find any matches for “Beta-I”.
